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Abstract
Impaired tolerance to distress may help explain part of the cognitive and functional impairments in 
schizophrenia. This project investigated distress intolerance in schizophrenia patients (SZ) as 
compared to controls, and whether distress intolerance represented an independent domain in 
relationship to symptoms, cognition, and functional capacity. Healthy controls (n=43) and SZ 
(n=65) completed a psychological distress challenge experiment and their levels of intolerance to 
distress were estimated. SZ showed increased distress intolerance such that they were significantly 
more likely to terminate the distress challenge session early compared to controls. Greater distress 
intolerance was associated with reduced functional capacity and worse cognitive performance in 
SZ. Mediation analyses suggested that distress intolerance had an independent effect on functional 
capacity, while some of this effect was mediated by cognitive performance. Our results suggest 
that distress intolerance is a promising domain for treatment research, and functional capacity may 
be improved by targeting treatments towards SZ patient’s ability to tolerate distress.
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Understanding the contributing factors to functional impairment in persons with 
schizophrenia remains a critical research area. Schizophrenia is marked by heightened 
sensitivity to stress (Norman and Malla, 1993; Corcoran et al., 2003; Walker et al., 2008). 
This sensitivity, combined with reduced cognitive reserve (Barnett et al., 2006), may 
predispose those with the illness to have difficulty successfully navigating stress-inducing 
situations and completing tasks that invoke stress. It is known that as a group, schizophrenia 
patients (SZ) have reduced drive to pursue goal directed behavior and display altered 
physiological responses to induced stress (Albus et al., 1982; Breier et al., 1988; Jansen et 
al., 1998; Jansen et al., 2000). For example, SZ exposed to a mental arithmetic stress test 
displayed an abnormal prolonged cardiac autonomic response which is hypothesized to arise 
from alterations in central brain structures which leave patients unable to “switch off” the 
stress response (Castro et al., 2008). This autonomic dysfunction was also found in 
unaffected first-degree relatives, suggesting that this abnormality has a genetic etiology 
rather than being due to arousal secondary to the disease or psychiatric medication effects 
(Bar et al., 2010). It is unknown if a maladaptive stress response contributes to their inability 
to complete tasks that evoke stress. We utilized a distress intolerance (defined as an inability 
to persist in goal directed behavior while experiencing affective distress) paradigm to test 
this question (Leyro et al., 2010). Distress tolerance is a meta-emotion construct 
encompassing an individual’s evaluations of experiencing aversive emotional states in 
respect to their tolerability, influence on emotion regulation and functioning, specifically 
including tendencies to either avoid or attenuate aversive experiences (Simons and Gaher, 
2005). The definition of distress intolerance we employed bears resemblance to persistence, 
a trait-like dimension. Although the definition of persistence is not uniform, it is related to 
maintaining certain behavior for achieving reinforcement or a reward (Cloninger et al., 
1991). Other authors have described completion of experimental tasks, some of which were 
designed to evoke frustration or distress, wherein the participants had the option to give up 
attempts at completing the task, as task persistence (Brandon et al., 2003). In the latter case, 
the construct is closely related to distress tolerance. The construct of task persistence is built 
upon Eisenberger’s learned industriousness theory, which holds that organisms with prior 
experience being rewarded for high effort are more likely to persist at effortful tasks than are 
organisms with histories of being rewarded for low effort (Eisenberger et al., 1992). Thus, 
distress intolerance and task persistence are similar in that both are operationalized by 
experimental tasks measuring the duration of a person’s attempt; however they differ in their 
theory upon which the construct is based.
Distress intolerance has been found relevant to other psychiatric and pathological 
conditions, and adaptive response to stress is increasingly a target of psychological 
interventions (Daughters et al., 2005a; Daughters et al., 2005b; O’Cleirigh et al., 2007; Nock 
and Mendes, 2008). For example, high levels of affect reactivity and distress intolerance 
have been associated with poor outcome after substance abuse and pathological gambling 
treatment (Daughters et al., 2005a; Daughters et al., 2005b). Patients with distress 
intolerance experienced greater depression, substance use, and were less adherent to their 
medication (O’Cleirigh et al., 2007). Distress intolerance has also been found in adolescents 
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engaging in nonsuicidal self-injury (Nock and Mendes, 2008). To our knowledge, distress 
intolerance has not been examined in persons with schizophrenia in a laboratory setting.
We operationalized distress intolerance by measuring a behavioral response to laboratory 
tasks that induced psychological stress. We utilized paradigms in which participants had the 
option to terminate the distress challenge task early. To motivate participants not to 
terminate early, they were informed that their performance determined their monetary 
reward. Early termination of the stressful task could result from: increases in negative affect, 
decreased motivation to persist due to an inability to experience anticipatory pleasure, or 
from an impulsive decision, thus we assessed these attributes in relation to distress 
intolerance. Schizophrenia patients in particular have less anticipatory pleasure for goal 
directed activities (Gard 2007), thus we felt it was important to control for the constructs of 
anhedonia and avolition while exploring this stress paradigm. While cognitive functioning 
has previously been shown to represent a separate domain from stress induced emotional 
reactivity in SZ (Myin-Germeys et al., 2002), due to its association with functional outcome 
we investigated its relationship with distress intolerance. We investigated: 1) whether SZ 
had more or less intolerance to psychological distress as compared with healthy controls; 2) 
the extent to which negative and positive affect reactivity, clinical and cognitive 
impairments explained distress intolerance and functional capacity, and 3) the extent by 
which functional impairments in SZ are explained by distress intolerance.
2. Methods
2.1 Participants
Participants were 130 individuals, aged 18 to 62 years, including 43 healthy controls and 65 
outpatients with schizophrenia or schizoaffective disorder. Participants gave written 
informed consent as approved by the University of Maryland Institutional Review Board. 
Major medical and neurological illnesses, history of head injury with cognitive sequelae, 
mental retardation, substance dependence within the past six months, or current substance 
abuse (except nicotine) were exclusionary. The Structured Clinical Interview for DSM-IV 
was administered to all participants to obtain diagnoses, which were based on consensus 
agreement from two psychiatrists (First et al., 1995). Controls had no current Axis I 
diagnoses and no family history of psychosis in the prior two generations. Six SZ patients 
were not taking any antipsychotic medication and the remaining 59 patients were on 
antipsychotic medications, including six on first generation antipsychotics and 53 on second 
generation antipsychotics. Of the patients on antipsychotics, 11 were also on an 
antidepressant, five were on a mood stabilizer, and five were on a benzodiazepine. The 
median chlorpromazine dose equivalent of antipsychotic medication among patients taking 
antipsychotics was 525 (standard deviation=615).
2.2 Measures
2.2.1 Clinical, cognitive and functional capacity assessment—Overall clinical 
symptoms were assessed by the 20 item Brief Psychiatric Rating Scale (BPRS), while 
impulsiveness was measured using the Barratt Impulsiveness Scale (Overall and Donald, 
1962; Stanford et al., 2009). We measured negative symptoms using the Brief Negative 
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Symptom Scale (BNSS; Kirkpatrick et al., 2011), and examined the items comprising the 
anhedonia and avolition subscales in this analysis. Cognitive ability was assessed by a 
combined index of processing speed (Digit Symbol Coding subtest of the Wechsler Adult 
Intelligence Scale-3) and working memory (Digit Sequencing task from Brief Assessment of 
Cognition in Schizophrenia) which are considered the most robust cognitive domain deficits 
in SZ compared with controls (Dickinson et al., 2007; Knowles et al., 2010). Functional 
capacity was measured by the University of California, San Diego Performance-Based Skills 
Assessment-2 (UPSA-2; Mausbach et al., 2008).
2.2.2 Psychological stressor—Study participants completed an automated testing 
session which consisted of two psychological distress-inducing tasks, the order of which was 
varied randomly. One task was the computerized Paced Auditory Serial Addition Task 
(PASAT), during which participants used a computer mouse to select the correct sum of 
consecutive numbers presented briefly on a computer screen before the next number was 
presented [e.g. 2+4 (correct response=6) +5 (=9) +7 (=12)] (Lejuez et al., 2003). When an 
incorrect response was given, or a response was not given before the next number was 
presented, a loud (90 decibel) aversive explosion sound was played. The task consisted of 
two learning sessions followed by an experimental session. Speed of response and accuracy 
were measured and an algorithm automatically titrated the speed of the task presentation to 
provide similar challenges across participants.
The other task was the computerized Mirror-Tracing Persistence Task (MTPT; Strong et al., 
2003). Participants were asked to trace a red dot along the outline of a star shaped image on 
the computer screen using the mouse. Tracing was challenging because the cursor 
movement was opposite to the movement of the mouse. Errors, such as tracing outside the 
line or keeping the mouse stationary, were met with a loud aversive explosion sound. The 
MTPT task consisted of three learning sessions followed by an experimental session. The 
width of the star outline was titrated automatically depending on performance to make the 
challenge more even across participants. For both tasks, participants could quit the 
experimental session at any time, but were informed that the better they performed the 
greater the monetary bonus they would receive. The experimental trial in each task could 
last up to seven minutes. Participants were not told the maximum amount of time allowed 
for either task. A monetary bonus of $20 was given for not quitting and $10 was given if the 
participant quit one or both of the tasks, although this was only revealed after completion of 
the testing session.
Both the PASAT and the MTPT have been widely used as measures of distress intolerance 
(Daughters et al., 2005b; McHugh et al., 2011). They both induce psychological stress, with 
the magnitude of reported distress not correlating with distress intolerance itself, suggesting 
that the task captures a person’s inability to tolerate distress rather than just their level of 
distress (McHugh et al., 2011). In our design, we combined both tasks to reduce potential 
biases which may arise due to differences in cognitive vs. manual skill.
2.2.3 Self-report of affect reactivity—Participants completed the Positive and Negative 
Affect Schedule (PANAS) at three time points (pre-test, after the first task, and after the 
second task) during the study session to measure subjective affect reactivity (Watson et al., 
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1988). This scale consists of 10 negative affect symptoms and 10 positive affect symptoms 
rated on the scale 1=very slightly to 5=extremely. Negative affect represents a general 
dimension of subjective distress and includes the following mood states: afraid, scared, 
nervous, jittery, irritable, hostile, guilty, ashamed, upset, and distressed. Positive affect 
reflects a person’s level of pleasurable engagement and includes these mood states: active, 
alert, attentive, determined, enthusiastic, excited, inspired, interested, proud, and strong.
2.3 Data analyses
The primary measure of distress intolerance was defined as quitting the experimental trial in 
at least one of the stressor tasks. We analyzed this data as an ordered, combined variable 
where 0=persists on both tasks (tolerant to the distress), 1=quit one task early (moderately 
intolerant/tolerant to distress), and 2=quit both tasks (implying intolerance to distress). 
Adaptive functioning was conceptualized as persisting until the end of the task, yet we also 
examined group differences in time spent on the experimental trial of both tasks. We 
calculated an average error rate as the number of aversive sounds divided by the total 
number of seconds spent on the experimental trial of each task. We also explored distress 
induced affect reactivity, as measured by the separate maximum changes in negative and 
positive affect immediately after completing the tasks compared with baseline.
Ordered logistic regressions were utilized to test group differences on distress intolerance, 
and to explore the relationship between clinical variables and distress intolerance (Anderson 
and Philips, 1981). Two t-tests examined the difference in average time spent on the 
experimental trials between groups. Group differences in demographics and clinical 
measures were examined with ANOVA, Chi square, and Fishers exact tests and t-tests were 
used to test differences between groups on maximum change in negative and positive affect. 
A repeated measures ANOVA explored group, reactivity (baseline vs. maximum change in 
affect), and the group x reactivity interaction in the positive and negative affect ratings. 
Finally, causal mediation analyses tested if distress intolerance mediated the association 
between clinical variables and functional capacity and if symptoms and cognition mediated 
the association between distress intolerance and functional capacity (Imai et al., 2010; Hicks 
and Tingley, 2011). All analyses were performed using Stata 12 (StataCorp, 2011).
3. Results
3.1 Clinical characteristics
Patients and controls were frequency-matched in age (P=0.489) and sex (P=0.085), 
however, patients had lower education (P=0.004) and a greater percentage of smokers 
(P=0.014) compared with controls (Table 1). SZ had significantly more psychiatric 
symptoms, greater impulsiveness, worse functional capacity, and worse cognitive 
performance (all P<0.001).
3.2 Distress intolerance in schizophrenia
SZ patients showed increased distress intolerance such that they were significantly more 
likely to terminate the tasks early as compared to controls (Table 2). SZ had 2.84 times 
greater odds of quitting one or both tasks versus persisting on both tasks as compared to 
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controls (P=0.005). SZ had higher distress intolerance in both PASAT and MPTC tasks as 
compared to controls. Sex, age and smoking status were not significantly associated with 
distress intolerance (all P≥0.15). Persons with above high school education had lower odds 
of quitting one or both tasks as compared to those with a high school education or less 
(OR=0.32, P=0.001). After controlling for education, the association between SZ and 
distress intolerance remained significant (OR=2.31, P=0.031 for SZ vs. controls). SZ spent 
significantly less time on the experimental trials as compared to controls (P<0.001).
3.3 Distress intolerance in relation to clinical symptoms, cognition, and functional capacity
In controls distress intolerance was not significantly associated with symptoms, impulsivity, 
cognition, errors on the tasks or functional capacity (Table 3). In SZ, less distress intolerance 
was significantly associated with greater functional capacity (OR=0.94, P=0.004) and 
greater cognitive performance (OR=0.45, P=0.016), but not with total symptoms, 
impulsiveness, anhedonia or avolition. SZ that performed the task with more errors had 
significantly greater distress intolerance (OR=3.57, P=0.001).
To further examine whether distress intolerance in SZ influences functional capacity 
independently, through clinical and cognitive impairments, or vice versa, we modeled the 
UPSA-2 total score as the outcome, with distress intolerance as the predictor and cognition 
and BPRS total symptom score as mediators (Figure 1A). Symptoms minimally mediated 
the effect, explaining 2% of the effect of distress intolerance, whereas cognitive 
performance moderately (43% of effect; 95% CI=26% – 94%) mediated the association 
between distress intolerance and functional capacity. Re-arranging the model where 
cognition and symptoms were the predictors and distress intolerance was the mediator 
(Figure 1B); we found that distress intolerance did not significantly mediate the relationship 
between symptoms and functional capacity (indirect and direct effects not significant), and 
minimally mediated the effect of cognitive performance, explaining 11% (95% CI=8% – 
17%) of its effect on functional capacity.
3.4 Affect reactivity
A repeated measures ANOVA showed a significant main effect of negative affect reactivity 
(F=34.93, df=2, P<0.001) and a group main effect (F=9.04, df=1, P=0.003), but no group x 
reactivity interaction (F=1.49, df=2, P=0.229). SZ (F=10.37, df=1, P=0.002) had higher 
negative affect ratings as compared to controls. The large main effect of negative affect 
reactivity but no significant interaction suggests that this paradigm reliably evoked negative 
affect reactivity across groups with SZ showing “normal” increases in negative. Importantly, 
baseline negative affect or reactivity were not significantly associated with distress 
intolerance in any group (all P>0.459), therefore distress intolerance was not primarily 
driven by negative affect. Negative affect reactivity was not significantly associated with 
symptoms, cognition, and functional capacity (all P>0.407).
For positive affect, a repeated measures ANOVA showed a significant main effect of 
reactivity (F=12.85, df=1, P<0.001) but no group main effect (F=0.34, df=1, P=0.562) or 
group x reactivity interaction (F=3.13, df=1, P=0.0.080). This suggests that the groups had 
similar positive affect at baseline, and the paradigm reliably decreased positive affect 
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equivalently across groups. Similar to negative affect, baseline positive affect or reactivity 
were not significantly associated with distress intolerance in any group (all P>0.231; Table 
4). Positive affect reactivity was not significantly associated with the clinical measures (all 
P>0.107).
4. Discussion
In this study, we found relatively clear evidence of increased distress intolerance in SZ, 
which was significantly associated with their impaired functional capacity and cognition. 
Interestingly, distress intolerance was not associated with severity of psychiatric symptoms 
in SZ. Distress intolerance had an independent effect on functional capacity, and also an 
indirect effect on functional capacity through cognition.
Symptom severity and cognitive impairments are known to be related to functional capacity, 
which we replicated (Bowie and Harvey, 2005; Leifker et al., 2009). In line with prior work, 
SZ had greater negative affect at baseline, however in contrast to previous findings 
(Blanchard et al., 1998), SZ reported similar baseline positive affect as compared to 
controls. SZ and controls showed similar increases in negative affect and decreases in 
positive affect in response to the task, suggesting that: 1) SZ were not particularly more 
distressed, and 2) any potential lack of insight into SZ’s affective state did not preclude a 
change in affective ratings. Thus, participation in this distress challenge did not result in 
greater emotional reactivity in SZ as has been seen in response to other stressors, such as 
daily hassles (Myin-Germeys et al., 2001). The novel finding here is that distress 
intolerance, measured by a laboratory based distress-inducing paradigm, independently 
predicted functional capacity within SZ but not in controls. Additionally, only in the SZ 
group did errors predict terminating the tasks early. While controls may have had 
idiosyncratic reasons for terminating the task early, such as low motivation for the monetary 
bonus or boredom, SZ seem particularly sensitive to making errors and/or the negative 
aversive stimulus in terms of task persistence. Perhaps past experiences of failures combined 
with lower cognitive reserve in certain persons with SZ predispose them to exhibit 
maladaptive responses to distress, manifested here as early task termination.
Neurobiological abnormalities found in patients with schizophrenia may explain why a 
larger proportion of patients were distress intolerant, and why this behavioral trait may be 
relevant to functional capacity. Persons with schizophrenia demonstrate blunted error-
related responses in the anterior cingulate cortex which correspond to poorer performance. 
This decreased activation of the “reinforcement learning network” likely contributes to 
patients displaying behavior that is rigid and preservative rather than adaptive to 
circumstances and guided by outcome (Polli et al., 2008). Due to impairments in this 
network, SZ may have been less able to adapt their task strategy or performance, thus 
becoming more distressed or apathetic about pursing the reward. Additionally, unmedicated 
SZ patients have demonstrated reduced activation in the ventral striatum, a central 
component of the reward system, with reduced activation corresponding to greater negative 
symptoms (Juckel et al., 2006; Howes and Kapur, 2009). This abnormal activation likely 
interferes with processing of reward-predicting cues by dopamine release, further 
contributing to loss of motivation to pursue rewards.
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Through the mediation analysis in SZ we found that distress intolerance only explained a 
small percentage of the total effect between cognition and functional capacity, but the 
cognitive measure mediated about half of the effect of distress intolerance on functional 
capacity. Our interpretation is that distress intolerance influences functional capacity in part 
independently and in part through cognition, such that SZ with reduced cognitive ability 
could not persist under distress and choose quitting to reduce their distress as negative 
reinforcement theory would predict. This result is consistent with evidence suggesting that 
patients with greater cognitive impairments in memory and executive functioning use more 
avoidant coping strategies when faced with stress (Lysaker et al., 2005). Since over half of 
the distress intolerance effect on functional capacity was independent of cognition, our 
results add support to the hypothesis that sensitivity to stress in SZ does not result from 
cognitive impairments alone (Myin-Germeys and van Os, 2007). As distress intolerance was 
not associated with impulsiveness, this finding cannot be explained by SZ patients making 
impulsive decisions.
Our main finding is important since the measure of functional capacity, the UPSA-2, is 
regarded as a direct and valid estimate of functional disability that is being used as an 
outcome measure in treatment studies and is a significant predictor of schizophrenia 
patient’s ability to live independently (Harvey et al., 2007; Mausbach et al., 2008). Studies 
in other psychiatric conditions have also linked distress intolerance to less favorable clinical 
outcomes (Daughters et al., 2005a; Daughters et al., 2005b; O’Cleirigh et al., 2007; Nock 
and Mendes, 2008). The present finding leads to the question of whether remediation for 
functional capacity in schizophrenia could be achieved in part by targeting patients’ ability 
to tolerate psychological distress.
Limitations of this work include that our distress intolerance paradigm always incorporated 
an aversive sound, thus we were unable to assess task persistence without the aversive 
feedback. The data is cross-sectional, so despite some evidence of directionality from the 
mediation analyses, it remains difficult to determine causality between distress intolerance 
and other measures. It may be useful for future studies to employ other stress paradigms, 
such as those involving response to cold, pain, or embarrassment, to investigate the range of 
distress intolerance exhibited by SZ. It is unknown how responses to laboratory induced 
stress reflect responses to real life stressors; this is another important topic for future 
investigation. However, assessing the response to a standardized laboratory stressor does 
provide valuable information about an individual’s response to these types of 
psychologically stressful situations. Lastly, differences in task persistence may reflect 
individual differences in motivation to receive negative reinforcement (quitting the task and 
thus ending the aversive sound) relative to motivation to pursue positive reinforcement 
(greater payment for good performance). This is an important consideration since poor 
reward processing is a fundamental aspect of negative symptoms of schizophrenia (Gold et 
al., 2008). However, there was not a significant difference in BNSS scores between distress 
intolerant and distress tolerant patients in our sample, suggesting that distress intolerance in 
this population may not simply be a consequence of negative symptoms.
The current findings have implications for initiatives such as the NIMH Research Domain 
Criteria (RdoC) project that seek to identify and define dimensions of psychopathology that 
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cross nosological boundaries. Distress intolerance is prominent not only among individuals 
with psychotic disorders, but also those with substance abuse disorders, problematic 
gambling, and among self-injurious teens (Daughters et al., 2005a; Daughters et al., 2008; 
Nock and Mendes, 2008). “Frustrative non-reward” has been identified as an important 
construct in the negative valence domain of RdoC (NIMH, 2011), and distress intolerance 
paradigms such as that employed in this study may be a useful approach for examining this 
construct in human research.
In conclusion, we found SZ to be more likely than controls to experience distress 
intolerance, and distress intolerance has a large and independent influence on functional 
capacity, in addition to its indirect effect on functional capacity through cognition. Distress 
intolerance was not driven by greater affect reactivity. These results highlight the 
importance of distress intolerance as an important paradigm in the study of the etiology and 
treatment for schizophrenia.
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• Schizophrenia patients and healthy controls completed a psychological distress 
task.
• SZ displayed distress intolerance, more often quitting the distress challenge 
early.
• Distress intolerance corresponded to worse functional capacity and cognition in 
SZ.
• Treatment targeting SZ patient’s ability to tolerate distress may improve 
functioning.
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Mediation analysis of cognition index, symptoms, and distress intolerance on functional 
capacity in schizophrenia patients. 1A: Mediation analysis showing the percent of distress 
intolerance’s total effect on functional capacity mediated by psychiatric symptoms and 
cognitive performance. 1B: Mediation analysis showing the percent of psychiatric 
symptom’s total effect on functional capacity mediated by distress intolerance, as well as the 
percent of cognitive performance’s total effect on functional capacity mediated by distress 
intolerance. *=95% confidence interval contains zero, effect is not significant. UPSA-2: 
University of California Performance Skills Assessment 2. BPRS: Brief Psychiatric Rating 
Scale.
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Table 1
Sample demographics and clinical measures
Variable Healthy Controls n=43 SZ Patients n=65
Healthy Controls vs. SZ
Test Statistic P value
Age in years* 38.5 (12.8) 36.8 (12.1) t=0.69 0.489
Male sex, % 51.2% 67.7% X2=2.98 0.085
Race (% Caucasian: Black: Other)** 60:35:5 40:57:3 X2=4.87 0.027
Education (% high school or less vs. % some college or college 
graduate)
23:77 51:49 X2=8.18 0.004
Smoking Status, % current smokers 25.6% 49.2% X2=6.04 0.014
Brief Psychiatric Rating Scale Total Score* 23.3 (3.0) 40.6 (10.7) t=−10.25 <0.001
Barratt Impulsiveness Scale Total Score* 56.4 (9.5) 66.1(9.9) t=−5.02 <0.001
Brief Negative Symptom Scale Anhedonia* 0.6 (1.2) 5.1 (5.1) t=−5.65 <0.001
Brief Negative Symptom Scale Avolition* 1.0 (2.1) 3.9 (3.1) t=−5.32 <0.001
Cognitive Ability* 0.43 (0.7) −0.35 (0.8) t=5.34 <0.001
University of California San Diego Performance-Based Skills 
Assessment-2 Total Score*




Statistics based on Caucasian vs. African American race.
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Table 2
Distress intolerance by participant group
Variable Healthy Controls n=43 SZ Patients n=65
Healthy Controls vs. SZ
Odds Ratio P value
Distress intolerance (% quitting no tasks: % quitting 1 task: % 
quitting both tasks)
44:44:11 26:37:37 2.84 0.005
Quit PASAT (Addition Task), % 14 36 3.39 0.017
Quit MTPT (Star Tracing Task), % 53 71 2.13 0.069
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